Home \ Projects \ Biological Threat Reduction through Vaccine Research & Development

Biological Threat Reduction through Vaccine Research & Development

Project

Biological Threat Reduction through Vaccine Research & Development

This project supports CEPI’s ongoing efforts to proactively develop new vaccines and platforms for high-risk priority emerging infectious diseases of security concern (e.g. Lassa Fever, Nipah Virus, MERS-CoV, Chikungunya, Rift Valley Fever, Disease X) and to ensure equitable access for affected populations during outbreaks.

Risk Area(s) covered

Activities

Beneficiary Countries

Beneficiary Regions

Budget

24000000 CAD

Status

Completed
Start Date: January 1, 2017
End Date: December 31, 2023

ASI Database Release

Providers and Implementers ?

Related Projects & Programs

Contacts

No Contacts Found

Scroll to Top